Editorial
Fair Price for New AIDS Drugs
Published in AIDS Weekly, September 21st, 1998
Companies that bring potent new antiretroviral drugs to market deserve a reward in addition to compensation for development costs. But this reward cannot come at the cost of collapsing the fragile system that makes it possible for many people with HIV disease to stay alive.
Two new AIDS drugs are on the verge of entering the market: DuPont Pharma's efavirenz and Glaxo's abacavir. These drugs will mean life or death to many patients who already have failed currently available treatments. They will greatly strengthen the AIDS drug armamentarium.
How ironic it would be if overpricing of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1998-09-21)
More Articles from AIDS Weekly
- In Memoriam
Mary Lou Clements-Mann and Jonathan M. Mann - Conference Coverage (12th World AIDS)
Can HAART Return CD8+ T-Cell Subsets to Normal? - Conference Coverage (12th World AIDS)
Early HAART May Prevent CTL Exhaustion - Conference Coverage (12th World AIDS)
Healthy Epithelia Impervious To HIV - Coinfection (TB/HIV)
Disseminated Skin TB Often Fatal in AIDS - Fatigue
Testosterone Decreases HIV Fatigue, Improves Mood - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
